Efficacy and Tolerability of Olopatadine and Azelastine in a 2-Week Vasomotor Rhinitis Trial.
Phase of Trial: Phase III
Latest Information Update: 05 Apr 2011
At a glance
- Drugs Azelastine; Olopatadine
- Indications Vasomotor rhinitis
- Focus Therapeutic Use
- 05 Apr 2011 Status changed from not stated to completed.
- 04 Mar 2011 New trial record